Skip to main navigation Skip to search Skip to main content

The early neuroimagining diagnosis of Alzheimer's disease

  • Sean Page
  • , Jiao Jian-Ling
  • , Liu Timon Cheng-Yi
  • , Li Yan
  • , Liu Song-Hao

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Neuroimaging has played an important role in evaluating the Alzheimer's disease (AD) patients, and its uses are growing. Magnetic resonance imaging (MRI) may show the presence of cerebral infarcts and white matter disease. Single photon emission computed tomography (SPECT) and positron emission tomography (PET), which visualize such cerebral functions as glucose metabolism and blood flow, may provide positive evidence to support the diagnosis of AD. Electrical impedance tomography (EIT) is a recently developed technique which enables the internal impedance of an object to be imaged non-invasively.
    Original languageEnglish
    Pages (from-to)141-146
    Number of pages5
    JournalProceedings of SPIE - The International Society for Optical Engineering
    Volume4536
    DOIs
    Publication statusPublished - 2002

    Keywords

    • Alzheimer's disease
    • Neuroimaging diagnosis

    Fingerprint

    Dive into the research topics of 'The early neuroimagining diagnosis of Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this